4Barnes L W.Eveson J W,Reichart P,et al.World Health Organization classification of tumour.Pathology and genetics of head and neck tumours[M].Lyon:IARC Press,2005:66-70.
7Heffer D R.The truth about alveolar rhabdomyosarcoma[J].Ann Diagn Pathol,2003,7(4):259-263.
8Bahrani A,Gown A M,Baird G S,et al.Aberrant expression of eptithelial and neuroendocrine markers in alerolar rhabdomyosarcoma.A potentially serious diagnostic pitfall[J].Mod pathol,2008,21(7):795-806.
10Wehrli B M,Huang W,De Crombrugghe B,et al.Sox9,a master regulator of chondrogenesis,distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors[J].Hum Pathol,2003,34(3):263-269.
5Dias F L, Sa G M, Lima R A, et al. Patterns of failure and out- come in esthesioneuroblastoma [ J ]. Arch Otolaryngol Head Neck Surg,2003,129 ( 11 ) : 1186 - 1192.
6Sharma S, Sharma M C, Johnson M H,et al. Esthesioneuroblastoma-a clinicopathologic study and role of DNA topoisomerase alpha [ J ]. Pathol Oncol Res,2007,13 (2) : 123 - 129.
7Wang S L, Chen W T, Li S H ,et al. Expression of human telomerase reverse transcriptase and cyclinD1 in olfactory neuroblastoma [J]. APMIS,2007,115(1) :17 -21.
8Barnes E L,Eveson J W, Reichart P, et al. Pathology and genetics of head and neck tumours[ M]. Lyon: IARC Press,2005:66 - 70.
9Bhattacharyya N. Cancer of the nasal cavity: survival and factors influencing prognosis [ J ]. Arch Otolaryngol Head Neck Surg, 2002,128 (9) : 1079 - 1083.
10Jethanamest D, Morris L G, Sikora A G, et al. Esthesioneuroblastoma : a population-based analysis of survival and prognostic factors [J]. Arch Otolaryngol Head Neck Surg, 2007,133 ( 3 ) : 276 - 280.
2Fletcher C D M, Unni K K, Mertens F. World Health Organiza-tion of tumors patholog3" and genetics of tomols of soft tissue anti bone[ M ]. Lyon : IARC Press,2002:86 - 90.
3Guillou L, Gebhard S, Coindre J M. Lipomalous hemangiopericy- toma: a fat-containing variant of solitary fibrous tumor? Clinico- pathologic, immunohistochemical, and uhrastructural analysis of a series in favor of a unifying concept [ J ]. Hum Pathol,2000,31 (9) :1108 - 15.
4Granter S R, Badizadegan K, Fletcher C D. Myofibromatosis in a- dults, glmmngiopericytoma, and myopericytoma: a spectrum of tumors st~owing perivascular myoid differentiation [ J ]. Am J Surg pathod, 1998,22(5 ) :513 - 2.5.
5Lascaratos G, Gupta M, Bridges L, Macrae M. Myofibroma of the conjunctiva invading the cornea in infancy [ J ]. J Pediatr Ophthal- tool Strabismus,2010,21 : 1 - 3.
6Blizniukov 0 P. Smirnova E A, Ponomareva M V, Kozlov N A. hffantile myofibroma and mvofibromatosis clinical and moq3holog- ie assessment of eighteen cases[J]. Vopr Onknl, 2010,56 ( 4 ) : 435 - 42.
7Dumont C, Monforte M, Flandrin A, et al. Prenatal management of a congenital infantile fibrosarconaa: unexpected outcome [ J ]. Uhrasound Obstet Gyneco1,2011,37 ( 6 ) :733 - 5.
8Hirakawa N, Naka T, Yamamoto 1, et al. Oveqrcssion of bcl-2 protein in symvial sarcoma : a comparative study of other sott tissue spindle cell salaomas and an additinnal anal)sis by fluorescence in situ hybridization[J].Human Pathol, 1996,27 ( 10 ) : 1060 - 5.
9Gleason B C, Fletcher C D. Deep "benign" fibrous histocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating oc- casional metastatic potential[ J]. Am J Surg Pathol,2008,32(3 ) : 354 - 62.
